A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study investigates safety and efficacy of CP-690,550 in adult patients with moderate to
severe Crohn's disease. The study hypothesis is that at least one of the dose levels to be
tested will be more effective than placebo (inactive drug).